Regulation of macrophage immune responses by antipsychotic drugs

References

• Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 1963;20:140–144
   PubMedGoogle Scholar
• Haracz JL. The dopamine hypothesis: an overview of studies with schizophrenic patients. Schizophr Bull 1982;8:438–469
   PubMed Web of Science ®Google Scholar
• Tauscher J, Hussain T, Agid O, et al. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics. Am J Psychiatry 2004;161:1620–1625
   PubMed Web of Science ®Google Scholar
• Megens AA, Awouters FH, Schotte A, et al. Survey on the pharmacodynamics of the new antipsychotic risperidone. Psychopharmacology (Berl) 1994;114:9–23
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 2005;10:79–104
   PubMed Web of Science ®Google Scholar
• Farah A. Atypicality of atypical antipsychotics. Prim Care Companion J Clin Psychiatry 2005;7:268–274
   PubMedGoogle Scholar
• Wu Y, Blichowski M, Daskalakis ZJ, et al. Evidence that clozapine directly interacts on the GABAB receptor. Neuroreport 2011;22:637–641
   Web of Science ®Google Scholar
• Markowitz JS, Brown CS, Moore TR. Atypical antipsychotics. Part I: pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 1999;33:73–85
   PubMed Web of Science ®Google Scholar
• Horacek J, Bubenikova-Valesova V, Kopecek M, et al. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS drugs 2006;20:389–409
   PubMed Web of Science ®Google Scholar
• Ashby CR Jr, Wang RY. Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 1996;24:349–394
   PubMedGoogle Scholar
• Erbagci AB, Herken H, Koyluoglu O, et al. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm 2001;10:109–115
   PubMed Web of Science ®Google Scholar
• Zhang XY, Zhou DF, Cao LY, et al. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatry 2004;65:940–947
   PubMed Web of Science ®Google Scholar
• Cazzullo CL, Sacchetti E, Galluzzo A, et al. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:33–39
   PubMed Web of Science ®Google Scholar
• Kim DJ, Kim W, Yoon SJ, et al. Effect of risperidone on serum cytokines. Int J Neurosci 2001;111:11–19
   PubMed Web of Science ®Google Scholar
• Chen ML, Tsai TC, Wang LK, et al. Clozapine inhibits Th1 cell differentiation and causes the suppression of IFN-gamma production in peripheral blood mononuclear cells. Immunopharm Immunol 2012;34:686–694
   PubMed Web of Science ®Google Scholar
• Chen ML, Tsai TC, Lin YY, et al. Antipsychotic drugs suppress the AKT/NF-kappaB pathway and regulate the differentiation of T-cell subsets. Immunol Lett 2011;140:81–91
   PubMedGoogle Scholar
• Chen ML, Tsai TC, Wang LK, et al. Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-alpha-directed cell apoptosis in neutrophils. Int Immunopharmacol 2012;12:197–204
   PubMedGoogle Scholar
• Ucok A, Gaebel W. Side effects of atypical antipsychotics: a brief overview. World Psychiatry 2008;7:58–62
   PubMed Web of Science ®Google Scholar
• Arana GW. An overview of side effects caused by typical antipsychotics. J Clin Psychiatry 2000;61:5–11
   PubMedGoogle Scholar
• Atkin K, Kendall F, Gould D, et al. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996;169:483–488
   PubMed Web of Science ®Google Scholar
• Alvir JM, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 1993;329:162–167
   PubMed Web of Science ®Google Scholar
• Finkel B, Lerner AG, Oyffe I, Sigal M. Risperidone-associated agranulocytosis. Am J Psychiatry 1998;155:855–856
   PubMed Web of Science ®Google Scholar
• Dernovsek Z, Tavcar R. Risperidone-induced leucopenia and neutropenia. Br J Psychiatry 1997;171:393–394
   PubMed Web of Science ®Google Scholar
• Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011;11:723–737
   PubMed Web of Science ®Google Scholar
• Riedel M, Schwarz MJ, Strassnig M, et al. Risperidone plasma levels, clinical response and side-effects. Eur Arch Psychiatry Clin Neurosci 2005;255:261–268
   PubMed Web of Science ®Google Scholar
• Mauri MC, Volonteri LS, Colasanti A, et al. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin Pharmacokinet 2007;46:359–388
   PubMed Web of Science ®Google Scholar
• Magliozzi JR, Hollister LE, Arnold KV, Earle GM. Relationship of serum haloperidol levels to clinical response in schizophrenic patients. Am J Psychiatry 1981;138:365–367
   PubMedGoogle Scholar
• Gaskill PJ, Carvallo L, Eugenin EA, Berman JW. Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflamm 2012;9:203
   Google Scholar
• Nakano K, Higashi T, Takagi R, et al. Dopamine released by dendritic cells polarizes Th2 differentiation. Int Immunol 2009;21:645–654
   Google Scholar
• Roy B, Rai U. Dual mode of catecholamine action on splenic macrophage phagocytosis in wall lizard, Hemidactylus flaviviridis. Gen Comp Endocrinol 2004;136:180–191
   Google Scholar
• Ali RA, Qureshi MA, McCorkle FM. Profile of chicken macrophage functions after exposure to catecholamines in vitro. Immunopharm Immunol 1994;16:611–625
   PubMed Web of Science ®Google Scholar
• Gomez F, Ruiz P, Briceno F, et al. Macrophage Fcgamma receptors expression is altered by treatment with dopaminergic drugs. Clin Immunol 1999;90:375–387
   Google Scholar
• Carvalho-Freitas MI, Rodrigues-Costa EC, et al. In vitro macrophage activity: biphasic effect of prolactin and indirect evidence of dopaminergic modulation. Neuroimmunomodulation 2008;15:131–139
   Google Scholar
• Durk T, Panther E, Muller T, et al. 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int Immunol 2005;17:599–606
   PubMed Web of Science ®Google Scholar
• Cloez-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM. Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 2003;15:233–240
   PubMed Web of Science ®Google Scholar
• Menard G, Turmel V, Bissonnette EY. Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2. Clin Exp Immunol 2007;150:340–348
   PubMed Web of Science ®Google Scholar
• Delgado PL, Charney DS, Price LH, et al. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990;47:411–418
   PubMed Web of Science ®Google Scholar
• Marek GJ, Carpenter LL, McDougle CJ, Price LH. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacol 2003;28:402–412
   PubMed Web of Science ®Google Scholar
• Birkett JT, Arranz MJ, Munro J, et al. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport 2000;11:2017–2020
   PubMedGoogle Scholar
• Schreiber R, Brocco M, Audinot V, et al. (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 1995;273:101–112
   PubMedGoogle Scholar
• Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958–969
   PubMed Web of Science ®Google Scholar
• Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008;181:3733–3739
   PubMed Web of Science ®Google Scholar
• de las Casas-Engel M, Dominguez-Soto A, Sierra-Filardi E, et al. Serotonin skews human macrophage polarization through HTR2B and HTR7. J Immunol 2013;190:2301–2310
   Google Scholar